Neuroscience of HIV Conference

描述(由申请人提供)：本申请寻求支持 第十届国际艾滋病毒感染神经科学会议：基础和 “临床前沿2002”将于2002年6月19日至22日在德国杜塞尔多夫举行。 具体地说，由于这是一个在 美国大陆，请求支持邮寄、打印和 全体演讲人和会议组织者自#年起的旅费和住宿费 美国。这次会议的目标是，前身是卫星研讨会 参加国际艾滋病大会，就是要把世界各国的 研究该病的病理生理机制和临床表现的专家 人类的神经学、神经心理学和精神病学并发症 免疫缺陷病毒(HIV)感染。这次会议是一次有效率的会议 传播有关该病发病机制、表现和 治疗广泛的与艾滋病毒相关的神经系统疾病。它 在刺激富有成效的协调方面也被证明是非常有效的 以协作、多机构的方式进行研究，并作为 鼓励该学科的年轻研究人员的有效途径。这 关于艾滋病毒神经科学的国际会议已经确立了轨道 唱片。它是在1988年构思和开发的，当时联合创始人(Dr.J. Berger和R.Levy)认识到神经科学家可利用的论坛有限 在国际艾滋病会议上介绍和讨论 与艾滋病毒对神经系统的影响有关的工作。第一届年度 在第Vth国际艾滋病问题会议之前在魁北克市举行的会议 在蒙特利尔，有来自大约220名参与者，取得了巨大的成功 整个世界。随后的会议地点包括蒙特利， 加利福尼亚(1990)、帕多瓦(1991)、阿姆斯特丹(1992)、维也纳(1993)、温哥华 (1994年)、巴黎(1996年)、芝加哥(1998年)和爱丁堡(2000年)。出席 会议人数从150人到275人不等，在世界各地都有代表。 会议的形式是全体会议的组合，由 国际公认的与科学有关的当局(两者 讲台和海报)。随着会议的成熟， 附例和由具有广泛代表性的国际专家组成的咨询委员会 为大会设立了艾滋病毒神经科学研究所。这个 即将召开的会议的独特之处在于，它将与第四届 国际神经病毒学研讨会。它们之间有相当大的重叠 会议存在于组织委员会、与会者和 主题。《神经病毒学杂志》发表了这两个会议的摘要 一如既往。通过梳理HIV的神经科学会议和第四次会议 国际神经病毒学学会会议允许大幅节省成本 由于共享资源和费用而产生。Brian Wigdahl博士，国际 ISNV的联合主席是这笔赠款的联合调查员。

DESCRIPTION (provided by applicant): This application seeks support for the conference, "The Tenth International Neuroscience of HIV Infection: Basic and Clinical Frontiers 2002" to be held in Dusseldorf, Germany, June 19-22, 2002. Specifically, as this is an international conference to be held outside the continental United States, support is requested for mailing, printing, and the travel and lodging costs of the plenary speakers and conference organizers from the United States. The goal of this conference, formerly a satellite symposium to the International Conference on AIDS, is to bring together the world's experts in the pathophysiological mechanisms and clinical manifestations of the neurological, neuropsychological, and psychiatric complications of human immunodeficiency virus (HIV) infection. The conference serves as an efficient means to disseminate new information on the pathogenesis, manifestations and treatment of the broad range HIV-related disorders of the nervous system. It has also proven to be extremely effective in stimulating fruitful coordinated research efforts in a collaborative, multi-institutional fashion and as an effective avenue for encouraging young investigators in the discipline. This international conference on the neuroscience of HIV has an established track record. It was conceived and developed in 1988 when the co-founders (Drs. J. Berger and R. Levy) recognized the limited forum available to neuroscientists at the International Conference on AIDS for the presentation and discussion of works related to the effects of HIV on the nervous system. The first annual meeting held in Quebec City, prior to the Vth International Conference on AIDS in Montreal, was an unqualified success with over 220 participants from around the world. Subsequent sites of the conference have included Monterey, California (1990), Padua (1 991), Amsterdam (1992), Vienna (1993), Vancouver (1994), Paris (1996), Chicago (1998), and Edinburgh (2000). Attendance at the conference has varied from 150 to 275 persons with worldwide representation. The format for the conference is a combination of plenary sessions by internationally recognized authorities in association with scientific (both platform and poster) presentations. With the maturation of the conference, by-laws and an advisory board of international experts broadly representative of the neuroscience of HIV have been established for the Conference. The upcoming conference is unique in that it will be coupled with the Fourth International Symposium of Neurovirology. Considerable overlap between these conferences exists with respect to organizing committees, attendees, and topics. The Journal of Neuroviroloqy has published both conferences' abstracts routinely. By combing the both Neuroscience of HIV meeting and the 4th International Neurovirology Society meeting allows for significant cost savings resulting from shared resources and expenses. Dr. Brian Wigdahl, international co-chair of the ISNV, is a co-investigator on this grant.